Dr. Robert H. Brown, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 419
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
MA license 59575
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Newton Watertown Dermatology Assoc. PC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 419
- Services billed
- 1,982
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 972 | 174 |
| Established patient office or other outpatient visit, 20-29 minutes | 481 | 383 |
| Destruction of precancer skin growth, 1 growth | 269 | 221 |
| Biopsy of related skin growth, first growth | 133 | 116 |
| Destruction of skin growth, 1-14 growths | 99 | 90 |
| Destruction of precancer skin growth, 15 or more growths | 71 | 57 |
| Established patient office or other outpatient visit, 10-19 minutes | 51 | 50 |
| Biopsy of related skin growth, each additional growth | 44 | 31 |
| New patient office or other outpatient visit, 30-44 minutes | 34 | 34 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 30 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketoconazole Other prescribers in Brighton, MA | 170 |
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 70 |
| Dupixent Pen (dupilumab) Other prescribers in Brighton, MA | 60 |
| Halobetasol Propionate | 47 |
| Tacrolimus Other prescribers in Brighton, MA | 44 |
| Metronidazole Other prescribers in Brighton, MA | 32 |
| Clobetasol Propionate Other prescribers in Brighton, MA | 26 |
| Finasteride Other prescribers in Brighton, MA | 26 |
| Doxycycline Hyclate Other prescribers in Brighton, MA | 23 |
| Betamethasone Dipropionate Other prescribers in Brighton, MA | 22 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 7 payments worth $155 in total to this clinician.
| Organon LLC | $39.39 |
|---|---|
| Arcutis Biotherapeutics, Inc. | $39.36 |
| Incyte Corporation | $26.96 |
| AbbVie Inc. | $26.04 |
| Amgen Inc. | $22.87 |
| Food and Beverage | $155 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.